News By Tag
* Aspira Scientific
* Trifluoromethylation Reagent
* Fluorine Chemistry
* More Tags...
News By Location
Catylix, Inc. and Aspira Scientific to Produce and Distribute Hartwig Trifluoromethylator® Reagent
The Fastest, Easiest Way to Add CF3 Will Be Available World-Wide and In Bulk
Based on the discoveries of Professor John Hartwig, now at the University of California Berkeley, Trifluoromethylator®
Trifluoromethylation is a frequently used chemical reaction, particularly in the pharmaceutical and crop protection industries. Dr. John Chan, CEO of Aspira commented, “We are delighted to bring Aspira’s expertise in distribution and production to make this breakthrough trifluoromethylation reagent more widely available to both researchers and process chemists. As we bring down the cost, we anticipate wider application and significantly increased demand.” More information is available on the Aspira web site: http://aspirasci.com/
Dr. David Rozzell, CEO of Catylix, and Dr. John Chan, CEO of Aspira Scientific, will be available for consultations and meetings during the 2014 ACS Meeting and Exhibition in San Francisco on August 11 and 12 at Booth 1136.
About Catylix, Inc.
Catylix, Inc. is an early-stage company specializing in the development and commercialization of new fluorination chemistry and novel products for the incorporation of fluorine-containing functionality. For more information about Catylix please visit http://www.catylix.com
About Aspira Scientific
Aspira Scientific is a science-centric enterprise dedicated to empowering scientists reach their aspirations in chemical R&D. We achieve this goal through reducing the cost of basic and applied research by offering research products with superior value in terms of price and quality. By leveraging a truly global innovation ecosystem, we also make available a broader set of next-generation enabling tools for chemical synthesis. For organizations with developmental programs, we provide custom production services via “Collaborate Locally. Commercialize Globally.™” model to afford exceptional value in terms of innovation, quality and IP assurance, and cost-efficiency. For more information on realizing your scientific aspirations now and tomorrow, please visit www.aspirasci.com.
David Rozzell, Ph.D.
CEO, Catylix, Inc.
John Chan, Ph.D.
CEO, Aspira Scientific
David Rozzell, CEO Catylix, Inc.